ARTV Stock Analysis: Buy, Sell, or Hold?
ARTV - Artiva Biotherapeutics, Inc. Common Stock
$4.14
-0.04 (-0.96%)
▼
5d:
-14.64%
30d:
-2.13%
90d:
-0.72%
WAIT
LOW Confidence
Last Updated: February 3, 2026
Earnings: Mar 23, 2026
Get Alerted When ARTV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: ARTV is down 14.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: ARTV is down 14.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: ARTV is currently trading at $4.14, which is considered oversold relative to its 30-day fair value range of $4.21 to $4.77.
Technical Outlook: Technically, ARTV is in a uptrend. Immediate support is located at $3.72, while resistance sits at $5.10.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $17.00 (+310.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ARTV is in a uptrend. Immediate support is located at $3.72, while resistance sits at $5.10.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $17.00 (+310.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$4.21 -
$4.77
Company Quality Score
48/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 310.6% below Wall St target ($17.00)
- WARNING: Recommendation downgraded due to -14.6% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$4.21 -
$4.77
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$3.72
Resistance Level
$5.10
Current Trend
Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-1.61
Wall Street Target
$17.00
(+310.6%)
Revenue Growth (YoY)
-100.0%
Last updated: February 04, 2026 5:24 AM ET
Data refreshes hourly during market hours. Next update: 6:24 AM
Data refreshes hourly during market hours. Next update: 6:24 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ARTV showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Fred Aslan
SELL
25500 shares
2025-10-17
Fred Aslan
SELL
25500 shares
2025-08-15
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$66 | 57 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$112 | 57 HOLD |
|
RNA
Avidity Biosciences Inc |
STRONG BUY
15 analysts |
$75 | 59 HOLD |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
12 analysts |
$71 | 62 BUY |
|
ALLO
Allogene Therapeutics Inc |
STRONG BUY
14 analysts |
$7 | 62 BUY |
